The endocannabinoid system: A general view and latest additions

British Journal of Pharmacology

Volumn 141, Issue 5, 2004, Pages 765-774

  De Petrocellis, Luciano ^a   Cascio, Maria Grazia ^b   Di Marzo, Vincenzo ^b  

^a CNR   (Italy)

^b CNR   (Italy)

Author keywords

2 arachidonoylglycerol; Anandamide; Cannabinoid; Endocannabinoids; Phosphatidic; Receptor; Vanilloid

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; CARRIER PROTEIN; DRONABINOL; ENDOCANNABINOID; ENDOGENOUS COMPOUND; G PROTEIN COUPLED RECEPTOR; N ARACHIDONOYLDOPAMINE; NOLADIN; PHOSPHATIDIC ACID; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VIRHODAMINE;

CHEMICAL STRUCTURE; DRUG RECEPTOR BINDING; ESTERIFICATION; HYDROLYSIS; METABOLISM; METABOLITE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REACTION ANALYSIS; RECEPTOR INTRINSIC ACTIVITY; SHORT SURVEY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SYNTHESIS;

ANIMALS; ENDOCANNABINOIDS; HUMANS; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 1842611887     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705666     Document Type: Short Survey

References (99)

1. AHLUWALIA, J., URBAN, L., BEVAN, S. & NAGY, I. (2003). Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci., 17, 2611-2618.
2. BASAVARAJAPPA, B.S., SAITO, M., COOPER, T.B. & HUNGUND, B.L. (2003). Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur. J. Pharmacol., 466, 73-83.
3. BELTRAMO, M., STELLA, N., CALIGNANO, A., LIN, S.Y., MAKRIYANNIS, A. & PIOMELLI, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094-1097.
4. BEN-SHABAT, S., FRIDE, E., SHESKIN, T., TAMIRI, T., RHEE, M.H., VOGEL, Z., BISOGNO, T., DE PETROCELLIS, L., DI MARZO, V. & MECHOULAM, R. (1998). An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol., 353, 23-31.
5. BERDYSHEV, E.V., SCHMID, P.C., KREBSBACH, R.J. & SCHMID, H.H. (2001). Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J., 15, 2171-2178.
6. BERRENDERO, F., SEPE, N., RAMOS, J.A., DI MARZO, V. & FERNANDEZ-RUIZ, J.J. (1999). Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse, 33, 181-191.
7. BISOGNO, T., BERRENDERO, F., AMBROSINO, G., CEBEIRA, M., RAMOS, J.A., FERNANDEZ-RUIZ, J.J. & DI MARZO, V. (1999). Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun., 256, 377-380.
8. BISOGNO, T., HOWELL, F., WILLIAMS, G., MINASSI, A., CASCIO, M.G., LIGRESTI, A., MATIAS, I., SCHIANO MORIELLO, A., PAUL, P., GANGADHARAN, U., HOBBS, C., DI MARZO, V. & DOHERTY, P. (2003). Cloning of the first sn 1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signalling in the brain. J. Cell. Biol., 163, 463-468.
9. BISOGNO, T., MAURELLI, S., MELCK, D., DE PETROCELLIS, L. & DI MARZO, V. (1997a). Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem., 272, 3315-3323.
10. BISOGNO, T., MELCK, D., BOBROV, M.Y.U., GRETSKAYA, N.M., BEZUGLOV, V.V., DE PETROCELLIS, L. & DI MARZO, V. (2000). N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J., 351, 817-824.
11. BISOGNO, T., MELCK, D., DE PETROCELLIS, L. & DI MARZO, V. (1999b). Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J. Neurochem., 72, 2113-2119.
12. BISOGNO, T., SEPE, N., MELCK, D., MAURELLI, S., DE PETROCELLIS, L. & DI MARZO, V. (1997b). Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem. J., 322, 671-677.
13. BRACEY, M.H., HANSON, M.A., MASUDA, K.R., STEVENS, R.C. & CRAVATT, B.F. (2002). Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science, 298, 1793-1796.
14. BREIVOGEL, C.S., GRIFFIN, G., DI MARZO, V. & MARTIN, B.R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
15. CADAS, H., DI TOMASO, E. & PIOMELLI, D. (1997). Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci., 17, 1226-1242.
16. CHEMIN, J., MONTEIL, A., PEREZ-REYES, E., NARGEOT, J. & LORY, P. (2001). Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J., 20, 7033-7040.
17. CHEVALEYRE, V. & CASTILLO, P.E. (2003). Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron, 38, 461-472.
18. CRAIB, S.J., ELLINGTON, H.C., PERTWEE, R.G. & ROSS, R.A. (2001). A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br. J. Pharmacol., 134, 30-37.
19. CRAVATT, B.F., DEMAREST, K., PATRICELLI, M.P., BRACEY, M.H., GIANG, D.K., MARTIN, B.R. & LICHTMAN, A.H. (2001). Super-sensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U.S.A., 98, 9371-9376.
20. CRAVATT, B.F., GIANG, D.K., MAYFIELD, S.P., BOGER, D.L., LERNER, R.A. & GILULA, N.B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
21. CRAVATT, B.F. & LICHTMAN, A.H. (2003). Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr. Opin. Chem. Biol., 7, 469-475.
22. DE PETROCELLIS, L., BISOGNO, T., DAVIS, J.B., PERTWEE, R.G. & DI MARZO, V. (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett., 483, 52-56.
23. DE PETROCELLIS, L., BISOGNO, T., MACCARRONE, M., DAVIS, J.B., FINAZZI-AGRO, A. & DI MARZO, V. (2001). The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 12856-12863.
24. DEUTSCH, D.G., UEDA, N. & YAMAMOTO, S. (2002). The fatty acid amide hydrolase (FAAH). Prostaglandins Leukot. Essent. Fatty Acids, 66, 201-210.
25. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
26. DI MARZO, V., BISOGNO, T. & DE PETROCELLIS, L. (2001a). Anandamide: some like it hot. Trends Pharmacol. Sci., 22, 346-349.
27. DI MARZO, V., BISOGNO, T., DE PETROCELLIS, L., BRANDI, I., JEFFERSON, R.G., WINCKLER, R.L., DAVIS, J.B., DASSE, O., MAHADEVAN, A., RAZDAN, R.K. & MARTIN, B.R. (2001b). Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor 'hybrid' ligands. Biochem. Biophys. Res. Commun., 281, 444-451.
28. DI MARZO, V., BISOGNO, T., DE PETROCELLIS, L., MELCK, D., ORLANDO, P., WAGNER, J.A. & KUNOS, G. (1999). Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem., 264, 2 58-267.
29. DI MARZO, V., BISOGNO, T., SUGIURA, T., MELCK, D. & DE PETROCELLIS, L. (1998a). The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal-and basophillike cells: connections with anandamide. Biochem. J., 331, 15-19.
30. DI MARZO, V., BLUMBERG, P.M. & SZALLASI, A. (2002a). Endovanilloid signaling in pain. Curr. Opin. Neurobiol., 12, 372-379.
31. DI MARZO, V., DE PETROCELLIS, L., FEZZA, F., LIGRESTI, A. & BISOGNO, T. (2002b). Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids, 66, 377-391.
32. DI MARZO, V., DE PETROCELLIS, L., SUGIURA, T. & WAKU, K. (1996). Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Biochem. Biophys. Res. Commun., 227, 281-288.
33. DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686-691.
34. DI MARZO, V., GRIFFIN, G., DE PETROCELLIS, L., BRANDI, I., BISOGNO, T., WILLIAMS, W., GRIER, M.C., KULASEGRAM, S., MAHADEVAN, A., RAZDAN, R.K. & MARTIN, B.R. (2002c). A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. J. Pharmacol. Exp. Ther., 300, 984-991.
35. DI MARZO, V., LASTRES-BECKER, I., BISOGNO, T., DE PETROCELLIS, L., MILONE, A., DAVIS, J.B. & FERNANDEZ-RUIZ, J.J. (2001c). Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur. J. Pharmacol., 420, 123-131.
36. DI MARZO, V., MELCK, D., BISOGNO, T. & DE PETROCELLIS, L. (1998b). Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci., 21, 521-528.
37. DINH, T.P., CARPENTER, D., LESLIE, F.M., FREUND, T.F., KATONA, I., SENSI, S.L., KATHURIA, S. & PIOMELLI, D. (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A., 99, 10819-10824.
38. EDGEMOND, W.S., HILLARD, C.J., FALCK, J.R., KEARN, C.S. & CAMPBELL, W.B. (1998). Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol. Pharmacol., 54, 180-188.
39. EGERTOVA, M., GIANG, D.K., CRAVATT, B.F. & ELPHICK, M.R. (1998). A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. R. Soc. London B. Biol. Sci., 265, 2081-2085.
40. FEZZA, F., BISOGNO, T., MINASSI, A., APPENDINO, G., MECHOULAM, R. & DI MARZO, V. (2002). Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett., 513, 294-298.
41. FOWLER, C.J. & JACOBSSON, S.O. (2002). Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide - targets for drug development? Prostaglandins Leukot. Essent. Fatty Acids, 66, 193-200.
42. GLASER, S.T., ABUMRAD, N.A., FATADE, F., KACZOCHA, M., STUDHOLME, K.M. & DEUTSCH, D.G. (2003). Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. U.S.A., 100, 4269-4274.
43. GOPARAJU, S.K., UEDA, N., TANIGUCHI, K. & YAMAMOTO, S. (1999). Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol., 57, 417-423.
44. GUZMAN, M., SANCHEZ, C. & GALVE-ROPERH, I. (2002). Cannabinoids and cell fate. Pharmacol. Ther., 95, 175-184.
45. HAJOS, N. & FREUND, T.F. (2002). Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology, 43, 503-510.
46. HANUS, L., ABU-LAFI, S., FRIDE, E., BREUER, A., VOGEL, Z., SHALEV, D.E., KUSTANOVICH, I. & MECHOULAM, R. (2001). 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. U.S.A., 98, 3662-3665.
47. HERMANN, H., DE PETROCELLIS, L., BISOGNO, T., SCHIANO MORIELLO, A., LUTZ, B. & DI MARZO, V. (2003). Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell. Mol. Life Sci., 60, 607-616.
48. HILLARD, C.J., EDGEMOND, W.S., JARRAHIAN, A. & CAMPBELL, W.B. (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem., 69, 631-638.
49. HILLARD, C.J. & JARRAHIAN, A. (2003). Cellular accumulation of anandamide: consensus and controversy. Br. J. Pharmacol., 140, 802-808.
50. HUANG, S.M., BISOGNO, T., PETROS, T.J., CHANG, S.Y., ZAVITSANOS, P.A., ZIPKIN, R.E., SIVAKUMAR, R., COOP, A., MAEDA, D.Y., DE PETROCELLIS, L., BURSTEIN, S., DI MARZO, V. & WALKER, J.M. (2001). Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem., 276, 42639-42644.
51. HUANG, S.M., BISOGNO, T., TREVISANI, M., AL-HAYANI, A., DE PETROCELLIS, L., FEZZA, F., TOGNETTO, M., PETROS, T.J., KREY, J.F., CHU, C.J., MILLER, J.D., DAVIES, S.N., GEPPETTI, P., WALKER, J.M. & DI MARZO, V. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A., 99, 8400-8405.
52. JÁRAI, Z., WAGNER, J.A., VARGA, K., LAKE, K.D., COMPTON, D.R., MARTIN, B.R., ZIMMER, A.M., BONNER, T.I., BUCKLEY, N.E., MEZEY, E., RAZDAN, R.K., ZIMMER, A. & KUNOS, G. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 14136-14141.
53. KARLSSON, M., CONTRERAS, J.A., HELLMAN, U., TORNQVIST, H. & HOLM, C. (1997). cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem., 272, 27218-27223.
54. KATHURIA, S., GAETANI, S., FEGLEY, D., VALINO, F., DURANTI, A., TONTINI, A., MOR, M., TARZIA, G., LA RANA, G., CALIGNANO, A., GIUSTINO, A., TATTOLI, M., PALMERY, M., CUOMO, V. & PIOMELLI, D. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med., 9, 76-81.
55. KEMPE, K., HSU, F.F., BOHRER, A. & TURK, J. (1996). Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J. Biol. Chem., 271, 17287-17295.
56. KOZAK, K.R., CREWS, B.C., RAY, J.L., TAI, H.H., MORROW, J.D. & MARNETT, L.J. (2001). Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J. Biol. Chem., 276, 36993-36998.
57. KOZAK, K.R., GUPTA, R.A., MOODY, J.S., JI, C., BOEGLIN, W.E., DUBOIS, R.N., BRASH, A.R. & MARNETT, L.J. (2002b). 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. J. Biol. Chem., 277, 23278-23286.
58. KOZAK, K.R. & MARNETT, L.J. (2002a). Oxidative metabolism of endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids, 66, 211-220.
59. LICHTMAN, A.H., HAWKINS, E.G., GRIFFIN, G. & CRAVATT, B.F. (2002). Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J. Pharmacol. Exp. Ther., 302, 73-79.
60. LIU, Q., TONAI, T. & UEDA, N. (2002). Activation of N-acylethanolamine-releasing phospholipase D by polyamines. Chem. Phys. Lipids, 115, 77-84.
61. LOPEZ-RODRIGUEZ, M.L., VISO, A., ORTEGA-GUTIERREZ, S., LASTRES-BECKER, I., GONZALEZ, S., FERNANDEZ-RUIZ, J. & RAMOS, J.A. (2001). Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. J. Med. Chem., 44, 4505-4508.
62. MACCARRONE, M., BARI, M., DI RIENZO, M., FINAZZI-AGRO, A. & ROSSI, A. (2003a). Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros: evidence for a synergistic effect of leptin. J. Biol. Chem., 278, 32726-32732.
63. MACCARRONE, M., BARI, M., LORENZON, T., BISOGNO, T., DI MARZO, V. & FINAZZI-AGRO, A. (2000a). Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem., 275, 13484-13492.
64. MACCARRONE, M., DE PETROCELLIS, L., BARI, M., FEZZA, F., SALVATI, S., DI MARZO, V. & FINAZZI-AGRO, A. (2001). Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch. Biochem. Biophys., 393, 321-328.
65. MACCARRONE, M., DI RIENZO, M., FINAZZI-AGRO, A. & ROSSI, A. (2003b). Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3. J. Biol. Chem., 278, 13318-13324.
66. MACCARRONE, M., FIORUCCI, L. & ERBA, F. (2000b). Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors. FEBS Lett., 468, 176-180.
67. MACCARRONE, M., VAN DER STELT, M., ROSSI, A., VELDINK, G.A., VLIEGENTHART, J.F. & FINAZZI-AGRO, A. (1998). Anandamide hydrolysis by human cells in culture and brain. J. Biol. Chem., 273, 32332-32339.
68. MAINGRET, F., PATEL, A.J., LAZDUNSKI, M. & HONORE, E. (2001). The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J., 20, 47-54.
69. MARKEY, S.P., DUDDING, T. & WANG, T.C. (2000). Base-and acid-catalyzed interconversions of O-acyl-and N-acyl-ethanolamines: a cautionary note for lipid analyses. J. Lipid Res., 41, 657-662.
70. MCPARTLAND, J.M. & GLASS, M. (2003). Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates. Gene, 312, 297-303.
71. MCVEY, D.C., SCHMID, P.C., SCHMID, H.H. & VIGNA, S.R. (2003). Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J. Pharmacol. Exp. Ther., 304, 713-722.
72. MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINSKI, N.E., SCHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R. & COMPTON, D.R. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
73. MUKHOPADHYAY, S., SHIM, J.Y., ASSI, A.A., NORFORD, D. & HOWLETT, A.C. (2002). CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. Chem. Phys. Lipids, 121, 91-109.
74. OFFERTALER, L., MO, F.M., BATKAI, S., LIU, J., BEGG, M., RAZDAN, R.K., MARTIN, B.R., BUKOSKI, R.D. & KUNOS, G. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol., 63, 699-705.
75. OKA, S., TSUCHIE, A., TOKUMURA, A., MURAMATSU, M., SUHARA, Y., TAKAYAMA, H., WAKU, K. & SUGIURA, T. (2003). Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J. Neurochem., 85, 1374-1381.
76. ORTAR, G., LIGRESTI, A., DE PETROCELLIS, L., MORERA, E. & DI MARZO, V. (2003). Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem. Pharmacol., 65, 1473-1481.
77. PERTWEE, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 74, 129-180.
78. PETERSEN, G. & HANSEN, H.S. (1999). N-acylphosphatidylethanolamine- hydrolysing phospholipase D lacks the ability to transphosphatidylate. FEBS Lett., 455, 41-44.
79. PORTER, A.C., SAUER, J.M., KNIERMAN, M.D., BECKER, G.W., BERNA, M.J., BAO, J., NOMIKOS, G.G., CARTER, P., BYMASTER, F.P., LEESE, A.B. & FELDER, C.C. (2002). Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the cb1 receptor. J. Pharmacol. Exp. Ther., 301, 1020-1024.
80. PUFFENBARGER, R.A., KAPULINA, O., HOWELL, J.M. & DEUTSCH, D.G. (2001). Characterization of the 5′-sequence of the mouse fatty acid amide hydrolase. Neurosci. Lett., 314, 21-24.
81. ROSS, R.A., CRAIB, S.J., STEVENSON, L.A., PERTWEE, R.G., HENDERSON, A., TOOLE, J. & ELLINGTON, H.C. (2002). Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. J. Pharmacol. Exp. Ther., 301, 900-907.
82. SAGAN, S., VENANCE, L., TORRENS, Y., CORDIER, J., GLOWINSKI, J. & GIAUME, C. (1999). Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. Eur. J. Neurosci., 11, 691-699.
83. SALZET, M. & STEFANO, G.B. (2002). The endocannabinoid system in invertebrates. Prostaglandins Leukot. Essent. Fatty Acids, 66, 353-361.
84. SCHMID, H.H., SCHMID, P.C. & BERDYSHEV, E.V. (2002). Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. Chem. Phys. Lipids, 121, 111-134.
85. SCHMID, H.H., SCHMID, P.C. & NATARAJAN, V. (1996). The N-acylation-phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids, 80, 133-142.
86. SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227-230.
87. STELLA, N., SCHWEITZER, P. & PIOMELLI, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773-778.
88. SUGIURA, T., KOBAYASHI, Y., OKA, S. & WAKU, K. (2002). Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids, 66, 173-192.
89. SUGIURA, T., KONDO, S., SUKAGAWA, A., NAKANE, S., SHINODA, A., ITOH, K., YAMASHITA, A. & WAKU, K. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215, 89-97.
90. SUGIURA, T., KONDO, S., SUKAGAWA, A., TONEGAWA, T., NAKANE, S., YAMASHITA, A., ISHIMA, Y. & WAKU, K. (1996). Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. Eur. J. Biochem., 240, 53-62.
91. SUGIURA, T., YOSHINAGA, N. & WAKU, K. (2001). Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. Neurosci. Lett., 297, 175-178.
92. SZALLASI, A. & BLUMBERG, P.M. (1999). Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev., 51, 159-212.
93. UEDA, N., LIU, Q. & YAMANAKA, K. (2001). Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations. Biochim. Biophys. Acta, 1532, 121-127.
94. VAN DER STELT, M., VAN KUIK, J.A., BARI, M., VAN ZADELHOFF, G., LEEFLANG, B.R., VELDINK, G.A., FINAZZI-AGRO, A., VLIEGENTHART, J.F. & MACCARRONE, M. (2002). Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J. Med. Chem., 45, 3709-3720.
95. WALEH, N.S., CRAVATT, B.F., APTE-DESHPANDE, A., TERAO, A. & KILDUFF, T.S. (2002). Transcriptional regulation of the mouse fatty acid amide hydrolase gene. Gene, 291, 203-210.
96. WILLIAMS, E.J., WALSH, F.S. & DOHERTY, P. (2003). The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J. Cell. Biol., 160, 481-486.
97. WILSON, R.I. & NICOLL, R.A. (2002). Endocannabinoid signaling in the brain. Science, 296, 678-682.
98. WOODWARD, D.F., KRAUSS, A.H.P., CHEN, J., LAI, R.K., SPADA, C.S., BURK, R.M., ANDREWS, S.W., SHI, L., LIANG, Y., KEDZIE, K.M., CHEN, R., GIL, D.W., KHARLAMB, A., ARCHEAMPONG, A., LING, J., MADHU, C., NI, J., RIX, P., USANSKY, J., USANSKY, H., WEBER, A., WELTY, D., YANG, W., TANG-LIU, D.D., GARST, M.E., BRAR, B., WHEELER, L.A. & KAPLAN, L.J. (2001). The pharmacology of bimatoprost (Lumigan). Surv. Ophthalmol., 45, S337-S345.
99. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.